Table 3.
Correlation between serum NO level and baseline characteristics and laboratory parameters of patients. Pearson’s or Spearman’s correlation tests were used to evaluate correlations
| Variable | NO level | |
|---|---|---|
| r | P | |
| Age | -0.06 | 0.61 |
| Gender | 0.01 | 0.95 |
| Hypertension | 0.09 | 0.43 |
| Diabetes mellitus | 0.03 | 0.78 |
| COPD | 0.01 | 0.99 |
| Current smoking | 0.06 | 0.59 |
| Family history of CAD | -0.14 | 0.23 |
| Body mass index | 0.07 | 0.54 |
| Beta blocker use | -0.08 | 0.47 |
| ACE-I use | 0.01 | 0.97 |
| ARB use | -0.02 | 0.86 |
| Statin use | 0.15 | 0.19 |
| ASA use | 0.14 | 0.22 |
| SBP | 0.21 | 0.07 |
| DBP | 0.11 | 0.35 |
| FPG | 0.04 | 0.75 |
| LDL | 0.08 | 0.47 |
| HDL | -0.02 | 0.88 |
| Triglycerides | -0.07 | 0.56 |
| Hemoglobin | 0.17 | 0.14 |
| MPV | 0.01 | 0.91 |
| Platelet count | 0.1 | 0.37 |
| Uric acid | 0.11 | 0.36 |
| Urea | 0.02 | 0.84 |
| Creatinine | -0.07 | 0.5 |
| LVEF | 0.09 | 0.4 |
ACE-I - angiotensin-converting enzyme inhibitors; ARB - angiotensin II receptor blockers; ASA - acetylsalicylic acid; CAD - coronary artery disease; COPD - chronic obstructive pulmonary disease; DBP - diastolic blood pressure; FPG - fasting plasma glucose; HDL - high-density lipoprotein cholesterol; LDL - low-density lipoprotein cholesterol; LVEF – left ventricular ejection fraction; MPV - mean platelet volume; SBP - systolic blood pressure